Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

Similar articles for PubMed (Select 12217596)

1.

Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.

Langley PG, Underhill J, Tredger JM, Norris S, McFarlane IG.

J Hepatol. 2002 Oct;37(4):441-7.

PMID:
12217596
2.

Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.

Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA.

J Hepatol. 2006 Oct;45(4):584-91. Epub 2006 Jun 23.

PMID:
16876902
3.

Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.

Tamori A, Shinzaki M, Kosaka S, Hayashi T, Iwai S, Enomoto M, Habu D, Sakaguchi H, Kawada N, Hino M, Shiomi S, Nishiguchi S.

Liver Int. 2007 Feb;27(1):95-100.

PMID:
17241387
4.

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

Evans WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R, Kalwinsky D, Keller F, Khatib Z, Margolin J, Murray J, Quinn J, Ravindranath Y, Ritchey K, Roberts W, Rogers ZR, Schiff D, Steuber C, Tucci F, Kornegay N, Krynetski EY, Relling MV.

J Clin Oncol. 2001 Apr 15;19(8):2293-301.

PMID:
11304783
5.

Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.

Cao Q, Zhu Q, Shang Y, Gao M, Si J.

Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.

PMID:
19252404
6.

Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.

Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR.

Eur J Clin Pharmacol. 2009 Mar;65(3):249-55. doi: 10.1007/s00228-008-0589-0. Epub 2008 Dec 2.

PMID:
19048245
7.

Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.

Vannaprasaht S, Angsuthum S, Avihingsanon Y, Sirivongs D, Pongskul C, Makarawate P, Praditpornsilpa K, Tassaneeyakul W, Tassaneeyakul W.

Clin Ther. 2009 Jul;31(7):1524-33. doi: 10.1016/j.clinthera.2009.07.008.

PMID:
19695401
8.

An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.

Vestergaard T, Bygum A.

Clin Exp Dermatol. 2010 Mar;35(2):140-4. doi: 10.1111/j.1365-2230.2009.03446.x. Epub 2009 Jul 29.

PMID:
19663853
9.

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.

Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.

Ther Drug Monit. 2005 Aug;27(4):435-41.

PMID:
16044099
11.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soulé JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F.

Gastroenterology. 2000 Jun;118(6):1025-30.

PMID:
10833476
12.

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.

Pharmacogenetics. 2002 Aug;12(6):429-36.

PMID:
12172211
13.

TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.

Song DK, Zhao J, Zhang LR.

J Clin Pharm Ther. 2006 Dec;31(6):627-35.

PMID:
17176368
14.
15.

[Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].

Zhan ZP, Liang LQ, Yang XY, Wang YX, Huang M, Li H.

Zhonghua Yi Xue Za Zhi. 2007 Jul 3;87(25):1734-7. Chinese.

PMID:
17919375
16.

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.

Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE.

Ann Intern Med. 1997 Apr 15;126(8):608-14.

PMID:
9103127
17.

[Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].

Alvarez Beltran M, Infante Pina D, Tormo Carnicé R, Segarra Cantón O, Redecillas Ferreiro S.

An Pediatr (Barc). 2009 Feb;70(2):126-31. doi: 10.1016/j.anpedi.2008.10.010. Epub 2009 Feb 3. Spanish.

18.

Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people.

Ferucci ED, Hurlburt KJ, Mayo MJ, Livingston S, Deubner H, Gove J, Plotnik J, McMahon BJ.

Can J Gastroenterol. 2011 Jan;25(1):21-7.

19.

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.

Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, Meenan J, Yim A, Sanderson J.

Aliment Pharmacol Ther. 2002 Oct;16(10):1743-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk